<DOC>
	<DOCNO>NCT01046357</DOCNO>
	<brief_summary>This Phase I , first time human , randomise , blind , placebo-controlled , single ascend dose study healthy male volunteer conduct single centre . The effect food pharmacokinetics AZD7687 also study . The study consist two part , dose escalation part food interaction part . The two part run parallel . In total , 64 healthy volunteer divide 8 different panel ( 8 volunteer per cohort ) expose single dos dose escalation . Each subject receive dose , except volunteer include dose step repeat food interaction .</brief_summary>
	<brief_title>A Study Healthy Volunteers Assess Tolerability Blood Levels Single Dose AZD7687</brief_title>
	<detailed_description />
	<criteria>Healthy BMI 1930 No blood donation prior 30 day No clinical study prior 3 month</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>First human</keyword>
	<keyword>Safety</keyword>
</DOC>